Summary of Significant Accounting Policies (Details)	12 Months Ended
	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Summary of Significant Accounting Policies (Details) [Line Items]
Merger transaction using exchange ratio	0.4047
Accumulated deficit	$ (286,761,000)	$ (236,219,000)
Net losses	50,500,000	49,800,000
Cash outflows from operations	40.1	$ 22,600,000
Cash and cash equivalents	$ 38,900,000
Accounts receivable	19.00%
Total revenues	12.00%
Accounts receivables, percentage	10.00%
Telemedicine property equipment	$0	$0.1
Capitalized interest costs	$0.1	$0.1
Intangibles asset description	Intangible assets resulting from these acquisitions include hospital contracts relationships, non-compete agreements and trade names. Hospital contracts relationships are amortized over a period of 6 to 17 years using a straight-line method. Non-compete agreements are amortized over a period of 4 to 5 years using the straight-line method. The trade names represented by NeuroCall, JSA Health and Access Physicians are amortized over a period of 2 to 5 years using the straight-line method.
Consultations represented, percentage	70.00%	70.00%
Variable consultations represented revenue	27.00%	30.00%
Recognize revenue	$ 900,000	$ 1,100,000
Advertising expense	$ 1,000,000
Selling, general and administrative expense		$ 900,000
Tax benefit	50.00%
Common Stock [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Share based compensation dividend yield	0.00%